🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/10/1986 | 5,73 | 5,76 | 5,70 | 5,76 | -0,80% | 1,16% | 4.729.205 |
| 30/10/1986 | 5,80 | 5,83 | 5,78 | 5,80 | +1,62% | 0,80% | 16.736.141 |
| 29/10/1986 | 5,67 | 5,73 | 5,67 | 5,71 | +0,35% | 1,05% | 2.884.306 |
| 28/10/1986 | 5,74 | 5,75 | 5,67 | 5,69 | -0,12% | 1,27% | 3.112.560 |
| 27/10/1986 | 5,76 | 5,77 | 5,70 | 5,70 | -1,38% | 1,26% | 4.463.222 |
| 24/10/1986 | 5,81 | 5,83 | 5,75 | 5,78 | -0,46% | 1,37% | 4.942.368 |
| 23/10/1986 | 5,73 | 5,84 | 5,73 | 5,80 | +1,51% | 2,08% | 8.405.798 |
| 22/10/1986 | 5,69 | 5,75 | 5,66 | 5,72 | +0,82% | 1,63% | 5.702.587 |
| 21/10/1986 | 5,70 | 5,71 | 5,65 | 5,67 | -0,58% | 1,05% | 3.699.230 |
| 20/10/1986 | 5,74 | 5,74 | 5,65 | 5,71 | -1,49% | 1,62% | 4.723.546 |
| 17/10/1986 | 5,73 | 5,79 | 5,71 | 5,79 | +0,81% | 1,39% | 10.416.701 |
| 16/10/1986 | 5,69 | 5,76 | 5,66 | 5,75 | +1,52% | 1,75% | 9.788.530 |
| 15/10/1986 | 5,49 | 5,66 | 5,47 | 5,66 | +3,39% | 3,38% | 10.363.882 |
| 14/10/1986 | 5,45 | 5,49 | 5,44 | 5,47 | +0,98% | 0,85% | 6.238.325 |
| 13/10/1986 | 5,41 | 5,43 | 5,39 | 5,42 | +0,00% | 0,73% | 3.055.968 |
| 10/10/1986 | 5,47 | 5,50 | 5,39 | 5,42 | -1,21% | 2,06% | 4.953.686 |
| 09/10/1986 | 5,40 | 5,53 | 5,39 | 5,49 | +1,22% | 2,45% | 6.442.056 |
| 08/10/1986 | 5,38 | 5,46 | 5,37 | 5,42 | +0,25% | 1,60% | 4.450.018 |
| 07/10/1986 | 5,41 | 5,43 | 5,35 | 5,41 | +0,74% | 1,59% | 4.700.909 |
| 06/10/1986 | 5,32 | 5,39 | 5,29 | 5,37 | +1,38% | 1,99% | 3.631.320 |
| 03/10/1986 | 5,41 | 5,45 | 5,26 | 5,29 | -0,87% | 3,43% | 9.567.821 |
| 02/10/1986 | 5,29 | 5,35 | 5,28 | 5,34 | +0,37% | 1,38% | 5.200.805 |
| 01/10/1986 | 5,23 | 5,37 | 5,22 | 5,32 | +1,90% | 2,91% | 5.719.565 |
| 30/09/1986 | 5,27 | 5,34 | 5,20 | 5,22 | -0,75% | 2,76% | 5.853.499 |
| 29/09/1986 | 5,26 | 5,27 | 5,18 | 5,26 | -0,13% | 1,76% | 6.130.800 |
| 26/09/1986 | 5,29 | 5,35 | 5,22 | 5,27 | -0,13% | 2,51% | 4.804.661 |
| 25/09/1986 | 5,41 | 5,41 | 5,27 | 5,27 | -3,05% | 2,45% | 6.679.742 |
| 24/09/1986 | 5,33 | 5,45 | 5,29 | 5,44 | +2,88% | 2,99% | 9.452.750 |
| 23/09/1986 | 5,20 | 5,29 | 5,20 | 5,29 | +2,05% | 1,78% | 7.004.203 |
| 22/09/1986 | 5,20 | 5,20 | 5,14 | 5,18 | +0,26% | 1,02% | 5.613.926 |